Skip links

Digital Business Drives Continuous Growth

Jump To Section

Digital business is the key for enterprises to drive simplification and continuous growth. This may seem counterintuitive but digital business is not about complex disparate initiatives.

Transforming Businesses: Fusing Technology and Business for Growth

Digital business is the key for enterprises to drive simplification and continuous growth. This may seem counterintuitive but digital business is not about complex disparate initiatives. Rather it’s a way to bring the business and technology together to rapidly develop new capabilities that fuel growth and market share.

Despite heavily investing to build digital business capabilities, many enterprises have fallen short of expectations and achieving desired results. This has had a dampening effect on other enterprises who are hesitant to push digital business investments forward. Their reasoning is that it takes a long time, disrupts current business and its customers, and is too expensive. The key issue is not failing to achieve business outcomes with speed, it is not having true agile collaboration between business and technology in a simplified engineering environment.

Business generally does not know exactly what they need and the data which helps them to make decisions based on detailed insights. A big bang approach without an agile environment to collaborate will likely lead to a long and drawn-out process prone to failure. Alternatively, working together across the enterprise in short sprints (1-2 weeks) will build mutual understanding and trust between business and technology. This unified environment leads to a dramatic shift in momentum where the pace of incremental outcomes and results begin to accelerate.

Key Roles in Implementing a Digital Business Environment

It is crucial that the CEO champion and instill this culture for the business and technology to collaborate in a truly agile environment. Being able to decompose a roadmap into bite-sized outcomes will provide transparency and keep the teams aligned to achieve specific goals. Also, the CIO/CTO/CDO needs to identify a cloud-based digital platform to create a truly agile environment. This end-to-end model will also provide flexibility in leveraging current digital assets with new components.

Organizationally everyone plays a role to implement a digital business environment, no group should be excluded. It starts at the top and is inclusive across the enterprise, these roles and responsibilities include:

CEO will lead and instill the culture of agile, collaboration, a bite-sized approach across the enterprise in a consistent way. They will set the priorities, outcomes for growth, and KPIs to monitor.
CIO/CTO/CDO will establish an end-to-end cloud-based agile environment for business and technology to collaborate.
Practitioners who understand both the business and technology will create a well-groomed backlog of features and user stories with the associated definition of doneness and
Digital engineering teams collaborate with the business by creating and demonstrating effective end-to-end outcomes every sprint with speed.
DevSecOps teams, proactively establish secure engineering environments and continuously unblocks engineering teams to ensure their productivity and effectiveness.

Final Thoughts

To summarize, the key ingredients in driving digital business are taking a bite-sized approach, simplifying business workflows, and utilizing defined use cases so that every two weeks the business can see outcomes that build confidence and effectiveness. We have taken this approach with many large and mid-size enterprises across Financial Services, Payments, FinTech, CPG/Retail, Automotive, and Pharma industries. In these engagements, business and technology came together which resulted in tremendous value by achieving effective outcomes with speed.

Raj Vattikuti

Raj Vattikuti

Raj Vattikuti is an American-Indian entrepreneur, business executive and philanthropist. He is the Founder and Chairman of Altimetrik Corp. He is also the founder of Vattikuti Foundation. through which he is involved in many charitable causes.

Latest Reads


Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes